Skip to main content
Log in

Effect of allicor on platelet aggregationin vitro andex vivo

  • Experimental Methods for Clinical Practice
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

An extract of garlic powder in isotonic phosphate buffer and adjoen (bioactive compound isolated from garlic powder) suppress human blood platelet aggregation induced by ADP and arachidonic acidin vitro. Adjoen more effectively than aspirin inhibits ADP-induced platelet aggregation but is inferior to aspirin if platelet aggregation is induced by arachidonic acid.Ex vivo oral intake of one Allicor tablet significantly decreases rabbit platelet aggregation induced with ADP. It is suggested that long-acting garlic powder tablets prevent thromboembolic complications and are recommended for correcting hemostasis parameters in patients with atherosclerotic involvement of blood vessels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. K. M. Lakin and V. P. Baluda, in:Pressing Problems of Hemostasiology [in Russian], Moscow (1981), pp. 430–461.

  2. M. Ali and S. Y. Mohammed,Prostaglandins Leukot. Med.,25, 139–146 (1986).

    Article  PubMed  CAS  Google Scholar 

  3. R. Apitz-Castro, J. J. Badimon, and L. Badimon,Thromb. Res.,68, 145–155 (1992).

    Article  PubMed  CAS  Google Scholar 

  4. E. Block, S. Ahmad, J. L. Catalsamo,et al., J. Am. Chem. Soc.,108, 7045–7055 (1986).

    Article  CAS  Google Scholar 

  5. D. J. Boullin,Lancet,1, 776–777 (1981).

    Article  PubMed  CAS  Google Scholar 

  6. J. C. Debouzy, J. M. Neumann, M. Herve,et al., Eur. Biophys. J.,17, 211–216 (1989).

    Article  PubMed  CAS  Google Scholar 

  7. W. J. Dixon and M. B. Brown, in:Biomedical Computer Programs. P-Series, Berkeley (1977), pp. 185–196.

  8. Z. A. Gabbasov, E. G. Popov, I. Yu. Gavrilov, and E. Yu. Pozin,Thromb. Res.,54, 215–223 (1989).

    Article  PubMed  CAS  Google Scholar 

  9. H. Kiesewetter, F. Jung, E. M. Jung,et al., Eur. J. Clin. Pharmacol.,45, 333–336 (1993).

    Article  PubMed  CAS  Google Scholar 

  10. C. Legnani, M. Frascaro, G. Guazzaioca,et al., Arzneimittelforschung,43, 119–122 (1993).

    PubMed  CAS  Google Scholar 

  11. A. N. Orekhov, V. V. Tertov, I. A. Sobenin, and E. M. Pivovarova,Ann. Med.,27, 63–65 (1995).

    PubMed  CAS  Google Scholar 

  12. F. Rendu, D. Daveloose, J. C. Debouzy,et al., Biochem. Pharmacol.,38, 1321–1328 (1989).

    Article  PubMed  CAS  Google Scholar 

  13. R. R. Samson,Atherosclerosis,44, 119–120 (1982).

    Article  PubMed  CAS  Google Scholar 

  14. K. C. Srivastava,Prostaglandins Leukot. Med.,22, 313–321 (1986).

    Article  PubMed  CAS  Google Scholar 

  15. P. P. Steele, H. S. Weily, H. Davies, and E. Genton,Circulation,48, 1194–1200 (1973).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 124, No. 7, pp. 79–100, July, 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andrianova, I.V., Gabbasov, Z.A., Ionova, V.G. et al. Effect of allicor on platelet aggregationin vitro andex vivo . Bull Exp Biol Med 124, 706–708 (1997). https://doi.org/10.1007/BF02445068

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02445068

Key Words

Navigation